Tectonic Therapeutic, Inc. cash flow to debt ratio of -4.71K% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Tectonic Therapeutic, Inc.'s free cash flow has decreased 1.77% from $-59.24M last year to $-60.29M, signaling decreasing performance

Tectonic Therapeutic, Inc.'s debt to equity ratio is 0.02, which means that the company's assets are healthy financed, signaling financial stability.

Tectonic Therapeutic, Inc.'s debt has decreased relative to shareholder equity from 0.02 last year to 0.02 today, signaling strengthened financials

Tectonic Therapeutic, Inc. has a net cash position, so leverage is healthy.

Tectonic Therapeutic, Inc. earns at least as much interest as it pays. Interest obligations are fully covered.

Tectonic Therapeutic, Inc. has insufficient data to evaluate this check.

Tectonic Therapeutic, Inc.'s short-term assets of $257.36M exceed its short-term liabilities of $9.67M

Tectonic Therapeutic, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Tectonic Therapeutic, Inc.'s return on equity of -35.26%, is lower than 15.00%, indicating bad performance

Tectonic Therapeutic, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Tectonic Therapeutic, Inc. had positive net income in only 0 out of 5 years, indicating unstable earnings

Tectonic Therapeutic, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

Tectonic Therapeutic, Inc. has negative free cash flow, indicating cash burn

Tectonic Therapeutic, Inc.'s yearly earnings has decreased 27.89% since last year from $-57.98M to $-74.15M, signaling decreasing performance

Tectonic Therapeutic, Inc.'s yearly revenue has increased 0.00% since last year from $0.00 to $0.00, signaling increasing performance

ROIC -41.59% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Tectonic Therapeutic, Inc. has insufficient revenue history to calculate 3-year revenue CAGR.

Tectonic Therapeutic, Inc. had revenue growth in 5 out of 5 years, indicating consistent revenue performance

Tectonic Therapeutic, Inc. had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity

Tectonic Therapeutic, Inc. has insufficient data to evaluate this check.

Tectonic Therapeutic, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Tectonic Therapeutic, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Tectonic Therapeutic, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Tectonic Therapeutic, Inc. has insufficient data to evaluate this check.

Tectonic Therapeutic, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Tectonic Therapeutic, Inc. has a price-to-book ratio of 2.77x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Tectonic Therapeutic, Inc. has a price-to-sales ratio of 999.00x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue